Novartis AG (NVS)
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive catalyst • High growth potential **Sentiment:** Positive (95%) **Content type:** General